Companion Animal Welfare

Cat Welfare and Infectious Peritonitis Treatment

FIP antiviral treatments including GS-441524 have transformed outcomes for cats with this previously fatal disease. Understanding treatment access maximises welfare benefit.

Key Facts

GS-441524 and molnupiravir achieve cure rates above 85% for wet and dry FIP
Treatment requires 84 days minimum with some forms requiring longer courses
Licensed versions of GS-441524 are becoming available following regulatory approvals
Cost remains a barrier with unlicensed versions sometimes more accessible but variable quality
Neurological and ocular FIP require higher doses and longer treatment durations

Welfare Considerations

FIP antiviral treatment has transformed this condition from invariably fatal to commonly curable. Maximising access to effective, quality-assured treatment is the primary current welfare challenge.

What You Can Do

Seek specialist assessment promptly if FIP is suspected
Explore all funding options including insurance and specialist financial assistance
Use licensed products where available for assured quality
Monitor treatment response carefully and complete the full course